US2100593A - Process of preparing a substance increasing the blood pressure - Google Patents
Process of preparing a substance increasing the blood pressure Download PDFInfo
- Publication number
- US2100593A US2100593A US35673A US3567335A US2100593A US 2100593 A US2100593 A US 2100593A US 35673 A US35673 A US 35673A US 3567335 A US3567335 A US 3567335A US 2100593 A US2100593 A US 2100593A
- Authority
- US
- United States
- Prior art keywords
- blood pressure
- substance
- solution
- increasing
- kidneys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 title description 51
- 230000036772 blood pressure Effects 0.000 title description 45
- 238000000034 method Methods 0.000 title description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 36
- 239000000243 solution Substances 0.000 description 35
- 210000003734 kidney Anatomy 0.000 description 23
- 239000011780 sodium chloride Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- 238000000502 dialysis Methods 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- 230000001376 precipitating effect Effects 0.000 description 10
- 239000000706 filtrate Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000009738 saturating Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000007522 Fused Kidney Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- -1 for instance Chemical class 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000244 kidney pelvis Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000003574 melanophore Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- LPSWFOCTMJQJIS-UHFFFAOYSA-N sulfanium;hydroxide Chemical compound [OH-].[SH3+] LPSWFOCTMJQJIS-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
Definitions
- the present invention relates to'the prepare tion of a pharmacologically active substance which has particular properties increasing the blood pressure.
- the body increasing the blood pressure contained in the kidney may g be produced in a pure 'formfrom, the kidney,
- I e substance increasing the blood pressure is preferably obtained from-freshkidneys of warm-' bloodedanimals; fo'r'the preparation of a pressed cake kidneys-if desiredina frozen state, or also dried kidneys are comminuted and mixed 5 with thesusual additions, such an large quantity of "sand and a small amount of kieselguhr; care must be taken that thepressed cake so prepared 5 portion of the reducing the blood pres- Asto the'process it isvspecifled in the followexpressing it is freed sure besides other substances.
- the starting solution for the mane uiracture may also be prepared by treating the fresh magma of the kidneys by means of suitable organic solvents, such as,for instance, acetone-alcohols, ethers or mixtures of these sub- 15 stances.
- suitable organic solvents such as,for instance, acetone-alcohols, ethers or mixtures of these sub- 15 stances.
- the mainportion of the substance reducing the blood'pressure is thereby taken away from the magma of the kidney; after removing the solvent, the magma of the kidney is then ex- .tracted with appropriate agents, for instance, go
- a ,saltnsolution having a weakly alkaline or neutral reaction and of a small concentration; preferably in av sodium chloride concentration of 0,9to 5% or with weak organic acids, weak bases,
- bufler solutions or aqueous organic solvents such 2 as aqueous glycerine or aqueous alcohol.
- aqueous organic solvents such 2 as aqueous glycerine or aqueous alcohol.
- the solvent is eliminated by concentration in the vacuum and the residue is taken up with water.
- Thetotal amount of the starting solution obtained accordingto one ofthe methods above de 35 scribed is brought to a weakly acid reaction in a 'hydrogenion concentration of 3-5, and mixed. in order to precipitate the substance increasing the blood pressure, with salt until saturation ocon application ofsodium chloride the. 4
- the contents of salt, for instance, of sodium chloride in the internal dialysate does not fall below 34%, since otherwise danger occurs that there also precipitates the body raising the blood pressure.
- the internal dialysate is then freed from the suspended ballast substances by filtration or centrifugation; the filtrate contains the substance increasing the blood pressure. This operation may be repeated several times in order to enrich and further purify the substance raising the blood pressure.
- the filtrate obtained which is still rich in pigment is brought to a pH range between 3 and 4 whereby a small salt concentration is maintained; this can be carried out by the addition of inorganic or water-soluble organic acids, such as, for instance, hydrochloric acid, sulfuric acid, oxalic acid, tartaric acid, lactic acid or acetic acid.
- inorganic or water-soluble organic acids such as, for instance, hydrochloric acid, sulfuric acid, oxalic acid, tartaric acid, lactic acid or acetic acid.
- an adsorbing agent such as kaolin, silica gel, aluminum oxide, colloidal iron oxide, activated carbon and.others.
- the substance increasing the blood pressure is dissolved again by treating the adsorbing agent with a weakly alkaline salt solution or by wea y alkaline organic solvents containing water; during this operation a pH range of about 7-8 in both directions must not be exceeded.
- the substance has the following properties: the blood pressure undergoes aprompt, slow, long lasting, increase when an effective amount is injected.
- the pressed ,cake is extracted several times with a sodium chloride solution of a small percentage, for instance, of about 5 per cent.
- the extract is dialyzed and added to the already dialyzed pressed juice.
- ballast substances precipitated during the dialysis are removed by filtration.
- the filtrate is mixed with sodium chloride at a pH of about 4+ preferably at a pH of 4.4-4.6 until saturation occurs.
- This hydrogen ion concentration is attained by an addition of acetic acid of preferably 2% strength.
- Theprocess of' preparing a substance increasing the blood pressure from kidneys or spleens which comprises extracting the organic .tilled water, precipitating the-substance increasing the blood pressure by saturating the solution with a salt usual for the precipitation-oi albumen at a pH of 3-5, extracting thesubstanceincreasing.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
- Patented Nov. 30, 1931 PATENT OFFICE aromas raocnss or minimum; A sUns'rAficE m canAsmo 'mn nnoonrnnssuan.
Georg Bessel and Hans Maier, Frankfort on-thc- No Drawing. Application August 10,1935, Serial No. 35,673. In Germany August 14, 1934 The present invention relates to'the prepare tion of a pharmacologically active substance which has particular properties increasing the blood pressure.
It is known. that .an aqueous extract from kid-'- neys causes an action reducing the blood pressure andan'action raising the blood pressure. Furthermore it is known that extracts obtained from kidneys bymeans of organic solvents show no action increasing the blood pressure. By ex-- tracting' kidneys by boiling them with the. aid of aqueous'solvents there can likewise not be obtained an extract whichscauses an action in-.-
creasingthe blood pressure.
Now we have found that the body increasing the blood pressure contained in the kidney may g be produced in a pure 'formfrom, the kidney,
furthermore from, the spleen-and from 'the'blood from warm bloo'ded animals according to a process which in its principal parts works in the following manner:
4 From the substance, for
from the kidney is produced-.from
which the component reducing heblood pressure is removed in a'suitable manner. r From this extractthe component raising the blood pressure is precipitated by treating the extract with an acidified salt solution. From this precipitate the substance increasing-"the blood pressure is -dissolved out-in a suitablemanner; thepigment and thealbuminoussubstances still contained in Lthe solution are'then eliminated andfrom the filtrate the component increasing the blood-pressure is extracted .with the "aid of adsorbing agents from-which itis'dissolved by'treating it with aqueous solutions having-a readily alkaline reaction.
' A0 I e substance increasing the blood pressure is preferably obtained from-freshkidneys of warm-' bloodedanimals; fo'r'the preparation of a pressed cake kidneys-if desiredina frozen state, or also dried kidneys are comminuted and mixed 5 with thesusual additions, such an large quantity of "sand and a small amount of kieselguhr; care must be taken that thepressed cake so prepared 5 portion of the reducing the blood pres- Asto the'process it isvspecifled in the followexpressing it is freed sure besides other substances. Since in the expremed cake still further quantities of the substance increasing the blood pressure are present, it is advantageous to extract the pressed cake several times with water to which preferably a 5 small amount of a salt with a neutral or weakly alkaline reaction is added and to dialyze the extract obtained; These extracts. are combined with the pressed juice already dialyzed.
Instead of preparing a pressed "cake from 10 ground kidneys the starting solution for the mane uiracture mayalso be prepared by treating the fresh magma of the kidneys by means of suitable organic solvents, such as,for instance, acetone-alcohols, ethers or mixtures of these sub- 15 stances. The mainportion of the substance reducing the blood'pressure is thereby taken away from the magma of the kidney; after removing the solvent, the magma of the kidney is then ex- .tracted with appropriate agents, for instance, go
with a ,saltnsolutionhaving a weakly alkaline or neutral reaction and of a small concentration; preferably in av sodium chloride concentration of 0,9to 5% or with weak organic acids, weak bases,
bufler solutions or aqueous organic solvents, such 2 as aqueous glycerine or aqueous alcohol. On ex-- traction with aqueous organic solvents; the solvent is eliminated by concentration in the vacuum and the residue is taken up with water. In
case glycerine is used dialysis with w'ater is 8111- 30- iicient. The aqueous solution thus -obtained serves as starting material for the further op-' eration.-
Thetotal amount of the starting solution obtained accordingto one ofthe methods above de 35 scribed is brought to a weakly acid reaction in a 'hydrogenion concentration of 3-5, and mixed. in order to precipitate the substance increasing the blood pressure, with salt until saturation ocon application ofsodium chloride the. 4
curs. most favorable hydrogen ion-range, measured "with the Wulif foil colorimeter, is between 4.4 and 4.6. The solution thus treated is kept at a temperature 0137 C. fora long time, for instance 16 to 24 hours, in anjncubatori Besides sodium chloride there may. also be used other salts usual for the precipitation of albuminous bodies, for instance, magnesium chloride, sodium sulfate, potassium chloride, magnesium 5o sulfate or ammonium sulfate; when the two last named salts are employed heating is "not necessary. Also in these cam 'caremustbetaken that animal used for vivisection).
electrolyte. It must, however, be considered that the contents of salt, for instance, of sodium chloride in the internal dialysate does not fall below 34%, since otherwise danger occurs that there also precipitates the body raising the blood pressure. The internal dialysate is then freed from the suspended ballast substances by filtration or centrifugation; the filtrate contains the substance increasing the blood pressure. This operation may be repeated several times in order to enrich and further purify the substance raising the blood pressure. The filtrate obtained which is still rich in pigment is brought to a pH range between 3 and 4 whereby a small salt concentration is maintained; this can be carried out by the addition of inorganic or water-soluble organic acids, such as, for instance, hydrochloric acid, sulfuric acid, oxalic acid, tartaric acid, lactic acid or acetic acid. By this acidification the pigments are precipitated whereas the body increasing the blood pressure remains in the dissolved state- The substance raising the blood pressure is adsorbed from the solution freed fromthe pigment by a sufllcient quantity of. an adsorbing agent, such as kaolin, silica gel, aluminum oxide, colloidal iron oxide, activated carbon and.others.
The substance increasing the blood pressure is dissolved again by treating the adsorbing agent with a weakly alkaline salt solution or by wea y alkaline organic solvents containing water; during this operation a pH range of about 7-8 in both directions must not be exceeded.
By elimination of the electrolyte and subsequent concentration of the aqueous solutions thus obtained a therapeutically highly active product is obtained.
The body obtained according to the process.
above describedis readily soluble in'water and in salt solutions of not too high a concentration; furthermore it is soluble in diluted organic acids, such-as acetic acid, lactic acid, carbonic acid and in strongly diluted mineral aci ds, such as sulfuric acid. It is furthermore soluble in hydrogen sulfide-water, weak alkalies,=snch as' sodium bicarbonate and secondary sodium phosphate. From aqueous solutions it is precipitated by the action of heavy metal salts and alkaloid precipitants. The body is insoluble in the usual organic solvents, such as alcohol, ether, acetone, petroleum ether, chloroform, ethylacetate, dioxane, etc. The body cannot be dialyzed and is inactivated by tryptic digestion, by heating it over 56 C. and by the action of strong acids and alkalies. w a
As to the pharmacological point of view, the substance has the following properties: the blood pressure undergoes aprompt, slow, long lasting, increase when an effective amount is injected.
We designate the amount of active substance by i which this action is attained as a biological unity.
As to its' weight a unit amounts, calculated per kilogram of animal, to 0.05 mg. ofdry substance.
(As an active quantity, calculated upon the-blood pressure of the dog in the biological test, we designate an increase of 30 mm. of mercury beyond the; formerly existing blood pressure of the The blood pressure thus increase'd is but slowly reduced; the
formerly existing blood pressure is reached withmoderate concentration.
in 30 to 60 minutes. The pharmacological test yields the following results:
Isolated vessels Contraction, i long lasting Heart Raising Intestine"; Small raising Uterus Not-influenced Iris Not-influenced Metabolism of the carbohydrate Not-influenced Water conservancy Not-influenced Melanophores Not-influenced Consequently the substance is adecided pharmacological body having a tonic effect on the vessels.
The following example serves to illustrate the invention, but it is not intended to limit it thereto:
15 fresh kidneys of pig are decapsulated, the renal pelvis and the adhering fat are removed and the kidneys thus prepared are strongly washed out with water containing toluene until they are practically. free from blood. On addition of a large amount of toluene these kidneys are passed through a meat mincing machine. After the toluene has been decanted 2 ldlos of sand are added to the mass, the magma triturated in the mortar and then by a further addition ofpressure can be detected any longer by animal test in the internal dialysate.
In order to obtain the amount of the substance increasing the blood pressure still contained in the pressed cake, the pressed ,cake is extracted several times with a sodium chloride solution of a small percentage, for instance, of about 5 per cent. The extract is dialyzed and added to the already dialyzed pressed juice.
The ballast substances precipitated during the dialysis are removed by filtration. For isolating the active substance the filtrate is mixed with sodium chloride at a pH of about 4+ preferably at a pH of 4.4-4.6 until saturation occurs. This hydrogen ion concentration is attained by an addition of acetic acid of preferably 2% strength.
By the saturation with sodium .chloride a. complete precipitation is attained in about 16 hours by keeping the batch in the incubator, if desired, with addition oftoluene, at a" temperature of 37 C. The precipitate is filtered and largely freed from adhering liquid. The residue which still moist is suspended in water and rapidly dialyzed for about 4-5 hours until in the internal dialysatethe content of sodium chloride has gone down to 2-5%. The precipitated ballast substances are eliminated by filtration. The filtrate may again be saturated with sodium chloride at the above indicated hydrogen ion concentration and the residue obtained-may be subjected to dialysis in a manner like that indicated above.
While the small content of sodium chloride in 7 this solution is maintained, the ballast substances,
chiefly pigments, which are still present are removed by precipitation at apH of 3-3.5, preferably t apH of 3.3-3.4. For the removal of these p ate it issu'itable to use a weak, organic acid. for instance, an aqueous lactic acid solution of a For 1000 cc. of the illtrate obtained as above described 60 cc. of a normal lactic acid are' generally suflicient in order to attain the indicated hydrogen ion c6n-- centration and in consequence the precipitation of the pigments. The ballast substances are eliminated by filtration from the liquid containing the active substance.
The adsorption of the substances increasing the I weakly yellow highly active filtrateisagainflltered and subjected to ultra-filtration, preferably with a weaklyalkaline reaction (pH about 7-8). The
ultra-filtrationds carried out with suitablealbu men-tight membranes. It is continued and the residue is waslieclout with twice distilled water free from carbonic acid until a drop of the filtrate does no longer leave any residue. In this condition the residue is concentrated in the vacuum overrsulfuric acid and caustic potash. The product' thusobtained is in its pulverized forma weakly yellow, highly active preparation of the properties indicated.
. It is advisable to carry out all steps as fal as possible with exclusion .of air; this is attained by covering the liquids with toluene or another suit- I able agent. 7
In order to obtain apreparatlon suitable for determination of the chemical constitution this dition of acetic acid of a small'concentration.
. above described after it has been frequently; washed out. A preparation which is further purl f the blood pressure iromthe precipitate with Most of the active substance is contained in the precipitate, whereas the filtrate contains contaminations. The same result is attained by the addition of heavy metal salts, 01- instance. an
aqueous solution of lead' acetatejto the aqueous solution of the therapeutically applicable product.
' In this case the precipitate is suspended in water,
hydrogen sulfide is introduced in order "to' precipitate the heavy metal sulfides and after the filtration the component increasing the blood pressure is obtained in the filtrate. After the hydro gen sulfide has been expelled the solution isliberated from the electrolytes by ultra-filtration. From the aqueous solution which does not pass the ultra-filter the substance is precipitated for *1 further purification by means of albunienand alkaloid-precipitants and extracted from the precipitate by aqueous solvents having an alkaline reaction. The electrolytes from this filtrate are again eliminated by ultra-filtration and the residue is concentrated under reduced pressure as fled is thus obtained.
1. Theprocess of' preparing a substance increasing the blood pressure from kidneys or spleens which comprises extracting the organic .tilled water, precipitating the-substance increasing the blood pressure by saturating the solution with a salt usual for the precipitation-oi albumen at a pH of 3-5, extracting thesubstanceincreasing.
the solution by acidifying the solution, treating the solution with an adsorbing agent and extracting the substance increasing the -blood pressure from the adsorbing agent by means of an aqueo solution of an alkaline substance. 2. The process of preparing a substance increasing the blood pressure from kidneys which comprises expressing the kidneys, extracting the pressed cake with a solution of sodium chloride water, precipitating the pigments contained inof about 5 per cent strength, removing the substance reducing the blood pressure from the pressed juice and the extract by dialysis, precipi tating the substance increasing the blood pressure by saturating the combined solutions with sodium chloride-at a pH of 4.4-4.6, extracting the sub stance increasing. the blood pressure-from the precipitate with water, precipitating the pigments containedjn the solution by acidifying the solution, treating the 'solution with an adsorbing agent and extracting the substance increasing the blood pressure from the adsorbing agent by means of an aqueous solution of an alkaline substance.
3. The process of preparing a substance in- I creasing the blood pressure from kidneys which comprises expressing the kidneys, extracting the pressed cake with a solution of sodium chloride of juice and the extract by dialysis, precipitating the substance increasing the-blood pressure by saturating the combined solutions with sodium chloride at a pH-oi 4.4-4.5 at a'temperature of 37 C., extracting the substance increasing the blood pressure from the precipitate with water, precipitating the pigments contained in the solution .by acidifying the solution, treating the solution with anadsorbing agent and extracting the substance increasing the blood pressure from the adsorbing agent by means of an'aqueous solution of an alkaline substance.
4. The process of preparing a substance increasing the blood pressure from kidneys which comprises expressing the kidneys, extracting the pressed cake with a solution of sodium chloride of about 5 per cent strength, removing the substance reducing the blood pressure from the pressed juice and the extract by dialysis .with distilled water, precipitating the substance increasing the blood pressure by saturating the combined solutions with sodium chloride at a pH of 4.4-4.6,
pressure from the-moist precipitate by dialysis with. distilled water, precipitating the pigments contained in the solution by acidifying the solution to a pH value of 3-4 while maintaining a sodium chloride concentration of 2-5 per cent, treating the solution with an adsorbing agent and extracting the substance increasing the blood pressure from the adsorbing agent by means ofan aqueous solution of an alkaline substance.
5. The process of preparing asubstance in creasing the'blood pressure from kidneys which comprises expressing thekidneys, extracting the pressed cake with a solution of, sodium chloride of about 5 per cent strength, removing the substance reducing the blood pressure from the pressed juice and the extract by dialysis with distilled watenprecipitating the substance increasing the blood pressure by saturating the'combined solu- Jlo tions with sodium chloride at a pH of 4.4-4.6, ex-
tracting the substance increasing the blood pres sure from the moist precipitate by dialysis with distilled water,.precipitating the pigments contained in the solution by acidifying the solution to a pH value of 3-4 while maintaining a. sodium chloride concentration of 2-5 per cent, treating the solution with kaolin and extracting the substance increasing the blood pressure from the adsorbing agent by means of an aqueous solution of secondary sodium phosphate.
- 6; The process of preparing a substance increasing the blood pressure from kidneys which comprises expressing the kidneys, extracting the prwsed cake with a solution of sodium chloride of about 5 per cent strength, removing the substance reducing the blood pressure irom the pressed juice and the extract by dialysis with distilled water, precipitating the substance increas- GEORG HESSEL. HANS MAIER.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2100593X | 1934-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2100593A true US2100593A (en) | 1937-11-30 |
Family
ID=7984944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US35673A Expired - Lifetime US2100593A (en) | 1934-08-14 | 1935-08-10 | Process of preparing a substance increasing the blood pressure |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2100593A (en) |
-
1935
- 1935-08-10 US US35673A patent/US2100593A/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108866134B (en) | Preparation method of silkworm pupa protein polypeptide chelated calcium | |
| Code et al. | The isolation of histamine from the white cell layer of centrifuged rabbit blood | |
| US3928322A (en) | Konjac mannan | |
| US3936375A (en) | Process for dewatering a proteinaceous, aqueous sludge and for removing and recovering precipitating agents from a precipitate containing proteinaceous substances | |
| US2410084A (en) | Recovery of heparin | |
| US3856945A (en) | Method of reducing serum cholesterol level with extract of konjac mannan | |
| Dodds et al. | Some observations on the properties and preparation of insulin, with special reference to the picrate-acetone method of preparation | |
| Dudley et al. | Improvements in the preparation of insulin. Alkaline extraction of pancreas | |
| US2871235A (en) | Process for obtaining polysaccharide material from plants of the genus cecropia | |
| US2190248A (en) | Process for obtaining a substance lowering the blood pressure | |
| US1984260A (en) | Process for preparing liquids containing active principles or hormones from parathyroid glands | |
| US1829270A (en) | Physiological mucin preparation | |
| US3262854A (en) | Method for the recovery of heparin | |
| US1669328A (en) | Specific antidiabetic principle | |
| US2424401A (en) | Circulatory hormone preparation and process of making the same | |
| US1488815A (en) | Vitamin body and method of preparing the same | |
| GB280969A (en) | Improved process for the purification of lactic acid | |
| RU2784435C1 (en) | Method for obtaining an agent with neuroprotective, immunomodulatory activity | |
| DE658210C (en) | Method for displaying a blood pressure increasing body | |
| DE950594C (en) | Method for obtaining heparin | |
| US1976175A (en) | Process of preparing adenosine phosphoric acid | |
| DE1963816A1 (en) | Mucoprotein, its manufacture and uses | |
| US2175014A (en) | Vitamin concentration | |
| SCHMITERLĂ–W | Some remarks on the determination of histamine with special reference to horse blood | |
| US1427645A (en) | Sadakichi satow |